Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies
- PMID: 28487471
- PMCID: PMC5461938
- DOI: 10.1042/CS20170146
Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies
Abstract
Diffusion tensor imaging (DTI) metrics such as fractional anisotropy (FA) and mean diffusivity (MD) have been proposed as clinical trial markers of cerebral small vessel disease (SVD) due to their associations with outcomes such as cognition. However, studies investigating this have been predominantly single-centre. As clinical trials are likely to be multisite, further studies are required to determine whether associations with cognition of similar strengths can be detected in a multicentre setting. One hundred and nine patients (mean age =68 years) with symptomatic lacunar infarction and confluent white matter hyperintensities (WMH) on MRI was recruited across six sites as part of the PRESERVE DTI substudy. After handling missing data, 3T-MRI scanning was available from five sites on five scanner models (Siemens and Philips), alongside neuropsychological and quality of life (QoL) assessments. FA median and MD peak height were extracted from DTI histogram analysis. Multiple linear regressions were performed, including normalized brain volume, WMH lesion load, and n° lacunes as covariates, to investigate the association of FA and MD with cognition and QoL. DTI metrics from all white matter were significantly associated with global cognition (standardized β =0.268), mental flexibility (β =0.306), verbal fluency (β =0.376), and Montreal Cognitive Assessment (MoCA) (β =0.273). The magnitudes of these associations were comparable with those previously reported from single-centre studies found in a systematic literature review. In this multicentre study, we confirmed associations between DTI parameters and cognition, which were similar in strength to those found in previous single-centre studies. The present study supports the use of DTI metrics as biomarkers of disease progression in multicentre studies.
Keywords: biomarkers; cerebral small vessel disease; clinical trials; cognition; diffusion tensor imaging.
© 2017 The Author(s).
Conflict of interest statement
The authors declare that there are no competing interests associated with the manuscript.
Figures


References
-
- Pantoni L. (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9, 689–701 - PubMed
-
- Román G.C., Erkinjuntti T., Wallin A., Pantoni L. and Chui H.C. (2002) Subcortical ischaemic vascular dementia. Lancet Neurol. 1, 426–436 - PubMed
-
- Patel B. and Markus H.S. (2011) Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int. J. Stroke 6, 47–59 - PubMed
-
- Hollocks M.J., Brookes R., Morris R.G. and Markus H.S. (2016) Associations between the Brief Memory and Executive Test (BMET), activities of daily living, and quality of life in patients with cerebral small vessel disease. J. Int. Neuropsychol. Soc. 22, 561–569 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials